Enhancing the therapeutic functionality of AAV vectors encoding dystrophin for preclinical DMD gene therapy studies

Project: Research

Description

dystrophin, gene therapy
StatusFinished
Effective start/end date1/10/0930/09/10

Funding

Muscular Dystrophy Campaign: £63,925, Muscular Dystrophy Campaign: £67,006, Muscular Dystrophy Campaign: £67,006

ID: 21681900